Phase II study of high dose weekly intravenous human lymphoblastoid interferon in renal cell carcinoma. A study of the National Cancer Institute of Canada Clinical Trials Group.
作者信息
Eisenhauer E A, Silver H K, Venner P M, Thirlwell M P, Weinerman B, Coppin C M
出版信息
Br J Cancer. 1987 May;55(5):541-2. doi: 10.1038/bjc.1987.110.
Abstract
摘要
相似文献
1
Phase II study of high dose weekly intravenous human lymphoblastoid interferon in renal cell carcinoma. A study of the National Cancer Institute of Canada Clinical Trials Group.高剂量每周静脉注射人淋巴母细胞干扰素治疗肾细胞癌的II期研究。加拿大国立癌症研究所临床试验组的一项研究。
Br J Cancer. 1987 May;55(5):541-2. doi: 10.1038/bjc.1987.110.
2
Antitumor effects of human lymphoblastoid interferon on advanced renal cell carcinoma.人淋巴母细胞干扰素对晚期肾细胞癌的抗肿瘤作用。
J Urol. 1988 Feb;139(2):256-8. doi: 10.1016/s0022-5347(17)42380-9.
3
[A study of the clinical response of renal cell carcinoma to human lymphoblastoid interferon (MOR-22)].[肾细胞癌对人淋巴母细胞干扰素（MOR-22）的临床反应研究]
Nihon Gan Chiryo Gakkai Shi. 1986 Jul 20;21(6):1277-84.
4
Phase II trial of interferon-beta-serine in metastatic renal cell carcinoma.
J Clin Oncol. 1990 May;8(5):881-5. doi: 10.1200/JCO.1990.8.5.881.
5
Interferon-alpha-n1 and continuous infusion vinblastine for treatment of advanced renal cell carcinoma.
J Biol Response Mod. 1990 Feb;9(1):108-11.
6
Treatment of renal cell carcinoma with daily low-dose alpha-interferon.每日低剂量α干扰素治疗肾细胞癌
J Biol Response Mod. 1989 Oct;8(5):453-61.
7
[Treatment of metastatic renal cell carcinoma with human lymphoblastoid interferon].用人淋巴母细胞干扰素治疗转移性肾细胞癌
Nihon Gan Chiryo Gakkai Shi. 1987 Jun 20;22(5):996-1002.
8
[The phase I and early phase II studies of human lymphoblast interferon (MOR-22) in the treatment of malignant tumors].人淋巴细胞干扰素（MOR-22）治疗恶性肿瘤的I期和早期II期研究
Nihon Gan Chiryo Gakkai Shi. 1986 Jun 20;21(5):1049-58.
9
[Immunotherapy of metastatic renal cell carcinoma with interleukin-2, interferon-alpha2a and erythropoietin-beta].[白细胞介素-2、α-2a干扰素和β-促红细胞生成素对转移性肾细胞癌的免疫治疗]
Urologe A. 2007 May;46(5):528-34. doi: 10.1007/s00120-007-1313-x.
10
Phase II study of 2'-deoxycoformycin in patients with renal cell carcinoma. A National Cancer Institute of Canada Clinical Trials Group study.2'-脱氧助间型霉素用于肾细胞癌患者的II期研究。加拿大国家癌症研究所临床试验组的一项研究。
Invest New Drugs. 1991 Aug;9(3):273-5. doi: 10.1007/BF00176983.
引用本文的文献
1
Phase II trial of LY 186641 in advanced renal cancer.LY 186641用于晚期肾癌的II期试验。
Invest New Drugs. 1993 Nov;11(4):323-8. doi: 10.1007/BF00874431.
2
Metastatic renal cell cancer--is the outlook really improving?转移性肾细胞癌——前景真的在改善吗？
Postgrad Med J. 1990 Jun;66(776):435-40. doi: 10.1136/pgmj.66.776.435.
本文引用的文献
1
Phase I study of weekly high-dose human lymphoblastoid interferon.
Cancer Treat Rep. 1984 Sep;68(9):1093-6.
2
Interferon-alpha therapy of renal cancer.
Cancer Res. 1984 Sep;44(9):4140-3.
3
Renal cell carcinoma: antitumor effects of leukocyte interferon.
Cancer Res. 1983 Feb;43(2):940-7.
4
Phase II study of interferon alpha in metastatic renal-cell carcinoma: a progress report.α干扰素治疗转移性肾细胞癌的II期研究：进展报告
J Clin Oncol. 1985 Aug;3(8):1086-92. doi: 10.1200/JCO.1985.3.8.1086.
Zotero 插件